المؤلفون: Riekkinen, Marianna, Pakkanen, Sari H., Hutse, Veronik, Roukaerts, Inge, Ollgren, Jukka, Käyhty, Helena, Herzog, Christian, Rombo, Lars, Kantele, Anu

المساهمون: Department of Medicine, Infektiosairauksien yksikkö, HUMI - Human Microbiome Research, HUS Inflammation Center, HUS Helsinki and Uusimaa Hospital District, Clinicum

مصطلحات موضوعية: Antibody, Coadministration, Hepatitis A, Hepatitis A vaccine, Immune interference, Immunogenicity, Pneumococcal conjugate vaccine, Pneumococcus, Travel, Vaccination, General medicine, internal medicine and other clinical medicine, 11832 Microbiology and virology

وصف الملف: application/pdf

العلاقة: AK reports a research grant from Valneva, unrelated to this manuscript. MR reports honoraria for lectures from GSK and Pfizer, and support for attending a conference from MSD, unrelated to this manuscript. LR reports honoraria for lectures from GSK, Pfizer, and Valneva, unrelated to this article. All other authors report no conflicts of interest. This work was supported by an investigator -initiated grant from Pfizer Oy, Finland (ID 53234819 to AK); the Finnish Governmental Subsidy for Health Science Research, Finland (to AK); and the Doctoral School in Health Sciences, University of Helsinki, Finland (to MR).; Riekkinen , M , Pakkanen , S H , Hutse , V , Roukaerts , I , Ollgren , J , Käyhty , H , Herzog , C , Rombo , L & Kantele , A 2023 , ' Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine : a randomized controlled trial ' , Clinical Microbiology and Infection , vol. 29 , no. 12 , pp. 1553-1560 . https://doi.org/10.1016/j.cmi.2023.08.006Test; ORCID: /0000-0003-4522-5337/work/150718922; http://hdl.handle.net/10138/569432Test; f6a0968d-7168-4899-979c-0eef23ea5425; 001127412600001

الإتاحة: http://hdl.handle.net/10138/569432Test

المؤلفون: Patjas, Anu, Kantele, Anu

المساهمون: HUMI - Human Microbiome Research, University of Helsinki, Infektiosairauksien yksikkö, HUS Inflammation Center, Department of Medicine

مصطلحات موضوعية: Urinary tract infections, UTI, Cystitis, Travelers' diarrhea, Pyelonephritis, LACTAMASE-PRODUCING ENTEROBACTERIACEAE, ESCHERICHIA-COLI, PREVALENCE, EPIDEMIOLOGY, ACQUISITION, RESISTANT, CARRIAGE, FEVER, General medicine, internal medicine and other clinical medicine, Public health care science, environmental and occupational health

وصف الملف: application/pdf

العلاقة: The work was supported by the Finnish Governmental Subsidy for Health Science Research [grant numbers: TYH 2012141, TYH 2013218 and TYH 2014216]; the Scandinavian Biopharma; the Sigrid Jus ' elius Foundation [grant number: 1726]; and Doctoral School in Health Sciences, University of Helsinki.; Patjas , A & Kantele , A 2022 , ' International travel and travelers' diarrhea - Increased risk of urinary tract infection ' , Travel medicine and infectious disease , vol. 48 , 102331 . https://doi.org/10.1016/j.tmaid.2022.102331Test; ORCID: /0000-0002-7882-0362/work/114303641; http://hdl.handle.net/10138/569819Test; 7530a4bc-a949-4046-8ef9-9d3c2f09b653; 000793766800002

الإتاحة: http://hdl.handle.net/10138/569819Test

المؤلفون: Aro, Tuomas, Kantele, Anu

المساهمون: Infektiosairauksien yksikkö, HUS Inflammation Center, Department of Medicine

مصطلحات موضوعية: Migrant, Migration, Asylum seeker, Refugee, Immigration, Immigrant, Undocumented migrant, Irregular migrant, Hospital, Infectious diseases, HEALTH, IMMIGRANTS, ABROAD, 3142 Public health care science, environmental and occupational health

وصف الملف: application/pdf

العلاقة: The authors thank Jukka Ollgren (Finnish Institute for Health and Welfare) for expert advice in statistical analyses and Ville Holmberg for valuable comments on the manuscript. This work was supported by the Finnish Governmental Subsidy for Health Science Research, the Sigrid Juselius Foundation, the Finnish Cultural Foundation, the Finnish Medical Foundation, Medical Society of Finland (Finska ladkaresadllskapet) , Finnish Society of Infectious Diseases Doctors (Suo-men Infektioladadkadrit) , and the Scandinavian Society for Antimicrobial Chemotherapy Foundation. The funding sources were not involved in study design, collection, analysis and interpretation of data, devising manuscript, and decision to submit the article for publication.; Aro , T & Kantele , A 2021 , ' Hospital admissions of refugees, asylum seekers and undocumented migrants : Ten-year retrospective study ' , Travel medicine and infectious disease , vol. 44 , 102186 . https://doi.org/10.1016/j.tmaid.2021.102186Test; c933f271-6d2a-4902-a535-4843fc219c75; http://hdl.handle.net/10138/354032Test; 000715050600011

الإتاحة: http://hdl.handle.net/10138/354032Test

المؤلفون: Holmberg, Ville, Salmi, Heli, Kattainen, Salla, Ollgren, Jukka, Kantele, Anu, Pynnönen, Juulia, Järvinen, Asko, Forsblom, Erik, Silén, Suvi, Kivivuori, Sanna Maria, Meretoja, Atte, Hästbacka, Johanna

المساهمون: Ville Holmberg's research group / Infections in Migrants, Department of Medicine, HUS Inflammation Center, Infektiosairauksien yksikkö, HUS Perioperative, Intensive Care and Pain Medicine, Anestesiologian yksikkö, Clinicum, HUS Head and Neck Center, Korva-, nenä- ja kurkkutautien klinikka, HUS Children and Adolescents, Children's Hospital, Helsinki University Hospital Area, Department of Diagnostics and Therapeutics

مصطلحات موضوعية: COVID-19, Ethnic, Language, Migrants, Minority, SARS-CoV-2, Vulnerable, 3121 General medicine, internal medicine and other clinical medicine, 11832 Microbiology and virology

وصف الملف: application/pdf

العلاقة: VH has received a grant from Finska L?kares?llskapet. AJ has received a grant from Wilhelm och Else Stockmanns stiftelse and speaker honoraria from Astellas, GlaxoSmithKline, Sanofi, Thermo Fisher, MSD, OrionPharma and UnimedicPharma. JH has recieved grants from NordForsk, Government research funding and Kirsti och Tor Johansson's hj?rt och cancerstiftelse. The authors declare that they have no other conflicts of interest in relation to this work. This work was supported by a research grant from Finska L?kares?llskapet. VH has received a grant from Finska Läkaresällskapet . AJ has received a grant from Wilhelm och Else Stockmanns stiftelse and speaker honoraria from Astellas , GlaxoSmithKline , Sanofi , Thermo Fisher , MSD , OrionPharma and UnimedicPharma . JH has recieved grants from NordForsk , Government research funding and Kirsti och Tor Johansson’s hjärt och cancerstiftelse . The authors declare that they have no other conflicts of interest in relation to this work. This work was supported by a research grant from Finska Läkaresällskapet .; Holmberg , V , Salmi , H , Kattainen , S , Ollgren , J , Kantele , A , Pynnönen , J , Järvinen , A , Forsblom , E , Silén , S , Kivivuori , S M , Meretoja , A & Hästbacka , J 2022 , ' Association between first language and SARS-CoV-2 infection rates, hospitalization, intensive care admissions and death in Finland : a population-based observational cohort study ' , Clinical Microbiology and Infection , vol. 28 , no. 1 , pp. 107-113 . https://doi.org/10.1016/j.cmi.2021.08.022Test; ORCID: /0000-0002-3613-7231/work/106339666; ORCID: /0000-0002-5866-9634/work/106341784; 85120737067; 0560ee32-bc8e-4435-974b-b433b6e174ae; http://hdl.handle.net/10138/338628Test; 000735207100017

الإتاحة: http://hdl.handle.net/10138/338628Test

المؤلفون: Kantele, Anu, Mero, Sointu, Lääveri, Tinja

المساهمون: Department of Medicine, HUS Inflammation Center, Clinicum, University of Helsinki, Infektiosairauksien yksikkö, HUMI - Human Microbiome Research, HUSLAB, Department of Diagnostics and Therapeutics

مصطلحات موضوعية: AMR, Antimicrobial resistance, Doxycycline, ESBL, Extended-spectrum beta-lactamase, Travellers' diarrhoea, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: This work was supported by a Finnish government subsidy for health science research [grant numbers: TYH 2012141 , TYH 2013218 and TYH 2014216 ], the Finnish Cultural Foundation , and the Sigrid Jusélius Foundation [grant number: 1726 ], Doctoral School in Health Sciences, University of Helsinki . This work was supported by a Finnish government subsidy for health science research [grant numbers: TYH 2012141, TYH 2013218 and TYH 2014216], the Finnish Cultural Foundation, and the Sigrid Jusélius Foundation [grant number: 1726], Doctoral School in Health Sciences, University of Helsinki.AK has received investigator-initiated grants from Valneva and Pfizer, neither of which are relevant for the current manuscript. SM and TL declare no conflicts of interest.; Kantele , A , Mero , S & Lääveri , T 2022 , ' Doxycycline as an antimalarial : Impact on travellers’ diarrhoea and doxycycline resistance among various stool bacteria – Prospective study and literature review ' , Travel medicine and infectious disease , vol. 49 , 102403 . https://doi.org/10.1016/j.tmaid.2022.102403Test; 85135688342; f77c194d-8375-4fb8-a359-3f100ef9bb51; http://hdl.handle.net/10138/347680Test; 000904134000009

الإتاحة: http://hdl.handle.net/10138/347680Test

المؤلفون: Lääveri, Tinja, Antikainen, Jenni, Mero, Sointu, Pakkanen, Sari H., Roivainen, Merja, Kantele, Anu

المساهمون: HUS Inflammation Center, Department of Medicine, Infektiosairauksien yksikkö, HUSLAB, Department of Bacteriology and Immunology, HUMI - Human Microbiome Research, Clinicum, Research Programs Unit, Faculty of Medicine

مصطلحات موضوعية: 3121 General medicine, internal medicine and other clinical medicine, Norovirus, Antibiotic, Ct-value, Diarrhoeagenic Escherichia coli, EAEC, ETEC

وصف الملف: application/pdf

العلاقة: This work was supported by a Finnish government subsidy for health science research (grant numbers: TYH2012141 , TYH 2013218 and TYH 2014216 ), the SSAC Foundation (grant number SLS-504141 ) and the Paulo Foundation . We express our gratitude to the late Dr Jukka Riutta and the nurses at the Travel Clinic of Aava Medical Centre for help in recruiting the volunteers.; Lääveri , T , Antikainen , J , Mero , S , Pakkanen , S H , Roivainen , M & Kantele , A 2021 , ' Bacterial, viral and parasitic pathogens analysed by qPCR: Findings from a prospective study of travellers' diarrhoea ' , Travel medicine and infectious disease , vol. 40 , 101957 . https://doi.org/10.1016/j.tmaid.2020.101957Test; ORCID: /0000-0003-4522-5337/work/88207574; 131d1bf4-da66-432f-b242-d3a2395170d0; http://hdl.handle.net/10138/338299Test; 000632850700004

الإتاحة: http://hdl.handle.net/10138/338299Test

المؤلفون: Kantele, Anu, Rombo, Lars, Vene, Sirkka, Kundi, Michael, Lindquist, Lars, Erra, Elina O.

المساهمون: Department of Medicine, HUS Inflammation Center, HUMI - Human Microbiome Research, Infektiosairauksien yksikkö

مصطلحات موضوعية: Tick -borne encephalitis, TBE, Middle-aged, Vector -borne, Central nervous system, TBE virus, TBE vaccination, TBE vaccine, BOOSTER VACCINATION, 0.5 ML, SAFETY, ADULTS, IMMUNOGENICITY, PERSISTENCE, ANTIBODIES, SEROPERSISTENCE, FSME-IMMUN(R), 3111 Biomedicine, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: This work was supported by Baxter, the Finnish Governmental Subsidy for Health Science Research, and Finska Lakaresallskapet. The vaccines were provided by Baxter. Serological analyses of blinded samples were conducted by Baxter in 2012. At that time, Baxter was the manufacturer and marketing authorization holder of FSME-Immun. Apart from that described above, the funding sources had no role in study design, data collection, data interpretation, writing of the report, or the decision to submit the article for publication. The corresponding author had full access to all the study data and ultimate responsibility for the decision to submit for publication.; Kantele , A , Rombo , L , Vene , S , Kundi , M , Lindquist , L & Erra , E O 2022 , ' Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older : A single-centre, open-label, randomized controlled trial ' , Vaccine , vol. 40 , no. 9 , pp. 1299-1305 . https://doi.org/10.1016/j.vaccine.2022.01.022Test; ed3cb217-01fd-4f05-bd6e-5597720765ba; http://hdl.handle.net/10138/342601Test; 000760201300016

الإتاحة: http://hdl.handle.net/10138/342601Test

المؤلفون: Turunen, Katri, Antikainen, Jenni, Lääveri, Tinja, Kirveskari, Juha, Svennerholm, Ann-Mari, Kantele, Anu

المساهمون: Department of Medicine, Department of Bacteriology and Immunology, HUS Inflammation Center, Infektiosairauksien yksikkö, Helsinki University Hospital Area, HUSLAB, Clinicum, Department of Diagnostics and Therapeutics

مصطلحات موضوعية: ETEC, LT, ST, STh, STp, Travellers' diarrhoea, COLONIZATION FACTORS, YOUNG-CHILDREN, MILITARY PERSONNEL, DISEASE BURDEN, ACUTE DIARRHEA, US TRAVELERS, DOUBLE-BLIND, PATHOGENS, STRAINS, INFANTS, General medicine, internal medicine and other clinical medicine, Public health care science, environmental and occupational health

وصف الملف: application/pdf

العلاقة: This work was supported by a Finnish Government Subsidy for Health Science Research (grant numbers: TYH 2012141, TYH 2013218 and TYH 2014216), the SSAC Foundation (grant number SLS-504141) and the Paulo Foundation. We express our gratitude to the late Dr Jukka Riutta and the nurses at the Travel Clinic of Aava Medical Centre for help in recruiting the volunteers.; Turunen , K , Antikainen , J , Lääveri , T , Kirveskari , J , Svennerholm , A-M & Kantele , A 2020 , ' Clinical aspects of heat-labile and heat-stable toxin-producing enterotoxigenic Escherichia coli : A prospective study among Finnish travellers ' , Travel medicine and infectious disease , vol. 38 , 101855 . https://doi.org/10.1016/j.tmaid.2020.101855Test; ORCID: /0000-0002-1272-081X/work/87353142; http://hdl.handle.net/10138/324924Test; 6291880b-242c-4dca-b7eb-4dfecc4b783d; 000600738600021

الإتاحة: http://hdl.handle.net/10138/324924Test

المؤلفون: Kantele, Anu, Lääveri, Tinja, Kareinen, Lauri, Pakkanen, Sari H., Blomgren, Karin, Mero, Sointu, Patjas, Anu, Virtanen, Jenni, Uusitalo, Ruut, Lappalainen, Maija, Järvinen, Asko, Kurkela, Satu, Jääskeläinen, Anne J., Vapalahti, Olli, Sironen, Tarja

المساهمون: Department of Medicine, HUS Inflammation Center, Clinicum, Department of Bacteriology and Immunology, University of Helsinki, HUMI - Human Microbiome Research, Department of Virology, Medicum, HUS Head and Neck Center, Korva-, nenä- ja kurkkutautien klinikka, Department of Diagnostics and Therapeutics, HUSLAB, Research Services, Veterinary Biosciences, Department of Geosciences and Geography, Olli Pekka Vapalahti / Principal Investigator, Viral Zoonosis Research Unit, Staff Services, Helsinki One Health (HOH), Veterinary Microbiology and Epidemiology, Emerging Infections Research Group

مصطلحات موضوعية: Healthcare staff, HCW, SARS-CoV-2, Covid-19, Antibody response, Neutralizing antibodies, 3142 Public health care science, environmental and occupational health, 11832 Microbiology and virology

وصف الملف: application/pdf

العلاقة: This work was supported by the Academy of Finland (grants 1336490, 336439 and 335527), the Juho Vainio Foundation, the Finnish Medical Foundation, private donors through UH, the Jane and Aatos Erkko Foundation, the EU Horizon 2020 programme VEO (grant 874735) and Helsinki University Hospital Funds (TYH 2018322). The funding sources were not involved in study design, data collection, data interpretation, writing of the manuscript, or the decision to submit the article for publication. The corresponding author had full access to all the study data and ultimate responsibility for the decision to submit for publication.; Kantele , A , Lääveri , T , Kareinen , L , Pakkanen , S H , Blomgren , K , Mero , S , Patjas , A , Virtanen , J , Uusitalo , R , Lappalainen , M , Järvinen , A , Kurkela , S , Jääskeläinen , A J , Vapalahti , O & Sironen , T 2021 , ' SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020 : Serosurvey, symptoms and risk factors ' , Travel medicine and infectious disease , vol. 39 , 101949 . https://doi.org/10.1016/j.tmaid.2020.101949Test; ORCID: /0000-0002-2344-2755/work/91247942; ORCID: /0000-0003-2270-6824/work/91247964; ORCID: /0000-0001-5400-1250/work/91248365; ORCID: /0000-0003-4522-5337/work/91249407; ORCID: /0000-0002-7882-0362/work/98976565; ORCID: /0000-0003-2911-3212/work/155656118; http://hdl.handle.net/10138/328346Test; 08ab5974-b933-4d6c-be79-ea0c386e5b6f; 000620092200021

الإتاحة: http://hdl.handle.net/10138/328346Test

المؤلفون: Haveri, Anu, Ikonen, Niina, Kantele, Anu, Anttila, Veli-Jukka, Ruotsalainen, Eeva, Savolainen-Kopra, Carita, Julkunen, Ilkka

المساهمون: Department of Medicine, Department of Bacteriology and Immunology, Anu Kantele-Häkkinen Research Group, Infektiosairauksien yksikkö, HUS Inflammation Center, University of Helsinki, HUS Internal Medicine and Rehabilitation

مصطلحات موضوعية: Antibodies, Microneutralization test, Humoral immunity, Influenza A, Pandemic, Vaccine, HEMAGGLUTINATION INHIBITION, H1N1 2009, ANTIGENIC STRUCTURE, PHASE-III, IMMUNOGENICITY, SAFETY, VACCINATION, CANDIDATE, CHILDREN, A(H3N2), 3111 Biomedicine, 1183 Plant biology, microbiology, virology, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: The study was supported by funds from the National Institute for Health and Welfare (THL) and the Ministry of Social Affairs and Health. The funding organization had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; Haveri , A , Ikonen , N , Kantele , A , Anttila , V-J , Ruotsalainen , E , Savolainen-Kopra , C & Julkunen , I 2019 , ' Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses ' , Vaccine , vol. 37 , no. 20 , pp. 2731-2740 . https://doi.org/10.1016/j.vaccine.2019.03.078Test; 2d1a0a66-5699-441a-b388-000250cd9eeb; http://hdl.handle.net/10138/312891Test; 000468718200012

الإتاحة: http://hdl.handle.net/10138/312891Test